GPT and neutropenia: The most common grade ≥ 3 AEs occurring in > 10% of patients were thrombocytopenia (17.3%) and neutropenia (14.7%) with asciminib and neutropenia (11.8%), diarrhea (10.5%), and increased alanine aminotransferase (14.5%) with bosutinib.